Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.6 USD | +0.30% |
|
+5.21% | 0.00% |
06-24 | ArriVent BioPharma, Inc.(NasdaqGM:AVBP) added to S&P Global BMI Index | CI |
06-05 | ArriVent, Alphamab Unit to Collaborate on Antibody Drug Conjugates For Cancer Treatment | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
621M | - | - | - | - | - | |
45.51B | - | |||||
38.52B | ||||||
38.13B | ||||||
30.74B | - | |||||
26.03B |